home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Human Pluripotent Stem Cells symposium: interrogating disease and development (April 22-24, 2009)

 
  January 28, 2009  
     
 
Abcam, Inc., Dublin, Ireland
04/22/09 - 04/24/09


This conference will focus on both basic and therapeutic applications of human pluripotent stem cells and their differentiated derivatives. Epigenetic and reprogramming mechanisms underpinning derivation, maintenance and differentiation of human pluripotent stem cells will be discussed. The emergence of human pluripotent stem cells as a platform for generating large quantities of disease-specific material will also be a key component of the meeting, focusing specifically on two applications: disease modeling and drug screening.

The conference boasts an impressive list of international speakers in this focused and rapidly expanding area of medical science and will constitute the first major stem cell meeting to be held in Ireland.

 
 
Organized by: Abcam, Inc.
Invited Speakers:
  • Dan Anderson (MIT)
    Combinatorial development of biomaterials for tissue engineering and drug delivery
  • Peter W Andrews (University of Sheffield)
    Population dynamics of human ES cells: self renewal, adaptation and cancer
  • Nissim Benvenisty (University of Jerusalem)
    The role of human embryonic stem cells in modeling human genetic disorders
  • Alan Colman (A*STAR Institute of Medical Biology, Singapore)
    Induced pluripotent stem cells and research into aging
  • Chad Cowan (Massachusetts General Hospital)
    Twists of fate: programming and reprogramming development
  • Gavin Davey (Trinity College Dublin)
    Using iPS cells for studying neurodegeneration
  • Hongkui Deng (Peking University)
    tbc
  • Chris Denning (University of Nottingham)
    In vitro utility of stem cell derived cardiomyocytes
  • Paolo Di Giorgio (Salk Institute of Biological Studies)
    Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model
  • Kevin Eggan (Stowers Medical Institute)
    Using new stem cell and reprogramming technologies to study disease: a case study in ALS
  • Konrad Hochedlinger (Harvard Medical School)
    Understanding nuclear reprogramming
  • Jeffrey Karp (Harvard Stem Cell Institute)
    Chemical engineering of the stem cell surface – towards targeted cell therapy
  • Rick Livesey (University of Cambridge)
    Modelling development and disease of the cerebral cortex in vitro
  • In-Hyun Park (Children's Hospital Massachusetts)
    Disease-specific induced pluripotent stem cells
  • Marc Peschanski (Institute for Stem Cell Therapy, Genopole)
    Pluripotent stem cells to explore mechanisms and treatments of monogenic diseases
  • Benjamin Reubinoff ( Hadassah Medical Organization, Jerusalem)
    Human Embryonic stem cells - towards future therapy of neurological disorders
  • Lee Rubin (Harvard University)
    Making neurons From ES cells: a better way to study neurodegenerative disease
  • Miodrag Stojkovic (University of Valencia)
    Why do we need embryonic and adult stem cells?
  • Lorenz Studer (Sloan Kettering Institute for Cancer Research)
    Modeling neural development and disease in human pluripotent cells
  • Azim Surani (University of Cambridge)
  • Ian Wilmut (University of Edinburgh)
    Stem cells in drug discovery and toxicology
  • Thomas Zwaka (Baylor College of Medicine, Texas)
    Embryonic stem cells: building alternative pluripotency networks

    Click here for speakers biographies

     

 
Deadline for Abstracts: 02/23/2009
 
Registration:

Early bird fee:       Standard rate:

 € 395 full             € 445 full

 € 295 students     € 345 students

Please note VAT is not applicable. All prices  include access to sessions; lunch and refreshments on 22, 23 and 24 April; attendance at the welcome reception; book of abstracts and other conference materials.

Students are categorized as those in full time education at the time of registering. Proof of student status may be requested.

Early bird deadline: Monday 23 February 2009 (standard rates apply after this time)

E-mail: ks@abcam.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.